{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:39:27Z","timestamp":1789987167983,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>To determine, in a region of Switzerland, the duration of retention in opioid substitution treatments with methadone (OSTM), duration of treatment interruptions, probability of re-entry to treatment after a treatment interruption, and associated factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A secondary analysis of registry-based data was performed with patients (<jats:italic>n<\/jats:italic>\u2009=\u20092880) registered in the methadone treatment register database of the Public Health Service of the canton of Vaud between January 1, 2001 and June 30, 2008. Survival analysis and multivariate analysis was conducted.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The probability of remaining on treatment was 69% at 1 year and 45% at 3 years (<jats:italic>n<\/jats:italic> =1666). One-third of patients remained on treatment beyond 5 years. The estimated hazard of leaving treatment was increased by a ratio of 1.31 in the case of a first treatment (<jats:italic>P<\/jats:italic>\u2009=\u20090.001), 1.83 for those without a fixed home (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), and 1.29 for those younger than 30 years old (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The probability of having begun a new treatment after a first interruption was 21% at one year, 38% at 3 years, and 43% at 5 years (<jats:italic>n<\/jats:italic>\u2009=\u20091581). Factors at the interruption of treatment associated with a higher probability of re-entering were: interruption not due to methadone withdrawal, bad physical health, and higher methadone dose.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>OSTM are long-term (maintenance) treatments in Switzerland. Younger age, bad living conditions at entry, and first treatment are predictors of lower retention. Approximately one-half of patients who interrupt treatment will re-enter treatment within 5 years.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-244x-12-238","type":"journal-article","created":{"date-parts":[[2012,12,28]],"date-time":"2012-12-28T07:14:33Z","timestamp":1356678873000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Methadone treatments in a Swiss Region, 2001\u20132008: a registry-based analysis"],"prefix":"10.1186","volume":"12","author":[{"given":"Th\u00e9r\u00e8se","family":"Huissoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Rousson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Dubois-Arber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,28]]},"reference":[{"key":"1145_CR1","unstructured":"Schorr D, K\u00fcnzi U: Was sagt uns die methadonstatistik \u00fcber die Entwicklung der letzten Jahre? Ein Vergleich zwischen ausgew\u00e4hlten Kantonen [What do the methadone statistics tell us about developments over the last few years?]. Abh\u00e4ngigkeiten. 2007, 22-31. 3"},{"key":"1145_CR2","unstructured":"Die Nationale Methadonstatistik. 2010, Bern: Bundesamt f\u00fcr Gesundheitswesen (BAG)"},{"key":"1145_CR3","first-page":"3","volume":"1","author":"M Hosek","year":"2006","unstructured":"Hosek M: Substitutionsbehandlungen in der Schweiz: Fortsetzung einer Erfolgsgeschichte. Suchtmagazin. 2006, 1: 3-9.","journal-title":"Suchtmagazin"},{"issue":"2","key":"1145_CR4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000097935","volume":"13","author":"H Waal","year":"2007","unstructured":"Waal H: Merits and problems in high-threshold methadone maintenance treatment. Evaluation of medication-assisted rehabilitation in Norway 1998\u20132004. Eur Addict Res. 2007, 13 (2): 66-73. 10.1159\/000097935.","journal-title":"Eur Addict Res"},{"issue":"7","key":"1145_CR5","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/j.1467-9566.2008.01094.x","volume":"30","author":"M Jarvinen","year":"2008","unstructured":"Jarvinen M: Approaches to methadone treatment: harm reduction in theory and practice. Sociol Health Illn. 2008, 30 (7): 975-991. 10.1111\/j.1467-9566.2008.01094.x.","journal-title":"Sociol Health Illn"},{"key":"1145_CR6","volume-title":"Aktuelle Praxis der Substitutionsbehandlung mit Methadon in der Schweiz 2000","author":"H Herrmann","year":"2001","unstructured":"Herrmann H: Aktuelle Praxis der Substitutionsbehandlung mit Methadon in der Schweiz 2000. 2001, Basel: Gesamtschweizerische Erhebung bei den an der \u00e4rtzlichen Opiatverschreibung Beteiligten une Betroffenen"},{"issue":"11","key":"1145_CR7","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/hec.999","volume":"14","author":"GA Zarkin","year":"2005","unstructured":"Zarkin GA, Dunlap LJ, Hicks KA, Mamo D: Benefits and costs of methadone treatment: results from a lifetime simulation model. Health Econ. 2005, 14 (11): 1133-1150. 10.1002\/hec.999.","journal-title":"Health Econ"},{"issue":"3","key":"1145_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/aje\/kwi035","volume":"161","author":"F Termorshuizen","year":"2005","unstructured":"Termorshuizen F, Krol A, Prins M, van Ameijden EJ: Long-term outcome of chronic drug use: the Amsterdam Cohort Study among Drug Users. Am J Epidemiol. 2005, 161 (3): 271-279. 10.1093\/aje\/kwi035.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"1145_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.drugalcdep.2005.01.013","volume":"79","author":"F Termorshuizen","year":"2005","unstructured":"Termorshuizen F, Krol A, Prins M, Geskus R, van den Brink W, van Ameijden EJ: Prediction of relapse to frequent heroin use and the role of methadone prescription: an analysis of the Amsterdam Cohort Study among drug users. Drug Alcohol Depend. 2005, 79 (2): 231-240. 10.1016\/j.drugalcdep.2005.01.013.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"1145_CR10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1001\/archpsyc.58.5.503","volume":"58","author":"YI Hser","year":"2001","unstructured":"Hser YI, Hoffman V, Grella CE, Anglin MD: A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry. 2001, 58 (5): 503-508. 10.1001\/archpsyc.58.5.503.","journal-title":"Arch Gen Psychiatry"},{"key":"1145_CR11","volume-title":"Substitution-assisted treatment in opioid dependence. Summary of the clinical recommendations for Substitution-assisted treatment (SAT) in opioid dependence issued by the SSAM (Swiss Society of Addiction Medicine) in 2007","author":"Swiss Society of Addiction Medicine","year":"2010","unstructured":"Swiss Society of Addiction Medicine: Substitution-assisted treatment in opioid dependence. Summary of the clinical recommendations for Substitution-assisted treatment (SAT) in opioid dependence issued by the SSAM (Swiss Society of Addiction Medicine) in 2007. 2010, Bern: Federal Office of Public Health"},{"key":"1145_CR12","volume-title":"Directives du M\u00e9decin cantonal concernant la prescription, la dispensation et l\u2019administration des stup\u00e9fiants destin\u00e9s \u00e0 la prise en charge de personnes d\u00e9pendantes (\u00e9tat le 01.05.2010)","author":"Service de la sant\u00e9 publique du canton de Vaud","year":"2010","unstructured":"Service de la sant\u00e9 publique du canton de Vaud: Directives du M\u00e9decin cantonal concernant la prescription, la dispensation et l\u2019administration des stup\u00e9fiants destin\u00e9s \u00e0 la prise en charge de personnes d\u00e9pendantes (\u00e9tat le 01.05.2010). 2010, Lausanne: D\u00e9partement de la sant\u00e9 et de l\u2019action sociale du canton de Vaud"},{"issue":"3","key":"1145_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3109\/00952991003736389","volume":"36","author":"M Mancino","year":"2010","unstructured":"Mancino M, Curran G, Han X, Allee E, Humphreys K, Booth BM: Predictors of attrition from a national sample of methadone maintenance patients. Am J Drug Alcohol Abuse. 2010, 36 (3): 155-160. 10.3109\/00952991003736389.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"8","key":"1145_CR14","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1111\/j.1360-0443.2009.02633.x","volume":"104","author":"L Burns","year":"2009","unstructured":"Burns L, Randall D, Hall WD, Law M, Butler T, Bell J, Degenhardt L: Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention. Addiction. 2009, 104 (8): 1363-1372. 10.1111\/j.1360-0443.2009.02633.x.","journal-title":"Addiction"},{"issue":"7","key":"1145_CR15","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1111\/j.1360-0443.2009.02627.x","volume":"104","author":"J Bell","year":"2009","unstructured":"Bell J, Trinh L, Butler B, Randall D, Rubin G: Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment. Addiction. 2009, 104 (7): 1193-1200. 10.1111\/j.1360-0443.2009.02627.x.","journal-title":"Addiction"},{"issue":"1","key":"1145_CR16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5055\/jom.2007.0036","volume":"3","author":"I Davstad","year":"2007","unstructured":"Davstad I, Stenbacka M, Leifman A, Beck O, Korkmaz S, Romelsjo A: Patterns of illicit drug use and retention in a methadone program: a longitudinal study. J Opioid Manag. 2007, 3 (1): 27-34.","journal-title":"J Opioid Manag"},{"issue":"1","key":"1145_CR17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF03405382","volume":"98","author":"M Perreault","year":"2007","unstructured":"Perreault M, Heroux MC, White ND, Lauzon P, Mercier C, Rousseau M: Treatment retention and evolution of clientele in a low threshold methadone substitution treatment program in Montreal. Can J Public Health. 2007, 98 (1): 33-36.","journal-title":"Can J Public Health"},{"key":"1145_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1477-7517-4-5","volume":"4","author":"II Michels","year":"2007","unstructured":"Michels II, Stover H, Gerlach R: Substitution treatment for opioid addicts in Germany. Harm Reduct J. 2007, 4: 5-10.1186\/1477-7517-4-5.","journal-title":"Harm Reduct J"},{"issue":"4","key":"1145_CR19","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jsat.2006.05.018","volume":"31","author":"KA Harris Jr","year":"2006","unstructured":"Harris KA, Arnsten JH, Joseph H, Hecht J, Marion I, Juliana P, Gourevitch MN: A 5-year evaluation of a methadone medical maintenance program. J Subst Abuse Treat. 2006, 31 (4): 433-438. 10.1016\/j.jsat.2006.05.018.","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"1145_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0376-8716(00)00211-8","volume":"62","author":"M Gossop","year":"2001","unstructured":"Gossop M, Marsden J, Stewart D, Treacy S: Outcomes after methadone maintenance and methadone reduction treatments: two-year follow-up results from the National Treatment Outcome Research Study. Drug Alcohol Depend. 2001, 62 (3): 255-264. 10.1016\/S0376-8716(00)00211-8.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"1145_CR21","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jsat.2008.07.002","volume":"36","author":"JR Havens","year":"2009","unstructured":"Havens JR, Latkin CA, Pu M, Cornelius LJ, Bishai D, Huettner S, Rapp C, Ricketts EP, Lloyd JJ, Strathdee SA: Predictors of opiate agonist treatment retention among injection drug users referred from a needle exchange program. J Subst Abuse Treat. 2009, 36 (3): 306-312. 10.1016\/j.jsat.2008.07.002.","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"1145_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1046\/j.1360-0443.1998.931516.x","volume":"93","author":"S Magura","year":"1998","unstructured":"Magura S, Nwakeze PC, Demsky SY: Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction. 1998, 93 (1): 51-60. 10.1046\/j.1360-0443.1998.931516.x.","journal-title":"Addiction"},{"issue":"1","key":"1145_CR23","first-page":"62","volume":"68","author":"S Magura","year":"2001","unstructured":"Magura S, Rosenblum A: Leaving methadone treatment: lessons learned, lessons forgotten, lessons ignored. Mt Sinai J Med. 2001, 68 (1): 62-74.","journal-title":"Mt Sinai J Med"},{"issue":"4","key":"1145_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jsat.2005.02.007","volume":"28","author":"L Amato","year":"2005","unstructured":"Amato L, Davoli M, Perucci CA, Ferri M, Faggiano F, Mattick RP: An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subst Abuse Treat. 2005, 28 (4): 321-329. 10.1016\/j.jsat.2005.02.007.","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"1145_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0376-8716(03)00002-4","volume":"70","author":"J Esteban","year":"2003","unstructured":"Esteban J, Gimeno C, Barril J, Aragones A, Climent JM, de la Cruz Pellin M: Survival study of opioid addicts in relation to its adherence to methadone maintenance treatment. Drug Alcohol Depend. 2003, 70 (2): 193-200. 10.1016\/S0376-8716(03)00002-4.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"1145_CR26","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/aje\/kwp186","volume":"170","author":"B Nosyk","year":"2009","unstructured":"Nosyk B, MacNab YC, Sun H, Fischer B, Marsh DC, Schechter MT, Anis AH: Proportional hazards frailty models for recurrent methadone maintenance treatment. Am J Epidemiol. 2009, 170 (6): 783-792. 10.1093\/aje\/kwp186.","journal-title":"Am J Epidemiol"},{"issue":"12","key":"1145_CR27","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.3109\/10826081003791932","volume":"45","author":"G Salamina","year":"2010","unstructured":"Salamina G, Diecidue R, Vigna-Taglianti F, Jarre P, Schifano P, Bargagli AM, Davoli M, Amato L, Perucci CA, Faggiano F: Effectiveness of therapies for heroin addiction in retaining patients in treatment: results from the VEdeTTE study. Subst Use Misuse. 2010, 45 (12): 2076-2092. 10.3109\/10826081003791932.","journal-title":"Subst Use Misuse"},{"key":"1145_CR28","doi-asserted-by":"publisher","first-page":"e5945","DOI":"10.1136\/bmj.e5945","volume":"345","author":"GJ Macarthur","year":"2012","unstructured":"Macarthur GJ, Minozzi S, Martin N, Vickerman P, Deren S, Bruneau J, Degenhardt L, Hickman M: Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ. 2012, 345: e5945-10.1136\/bmj.e5945.","journal-title":"BMJ"},{"issue":"3","key":"1145_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1465-3362.2009.00157.x","volume":"29","author":"Y Che","year":"2010","unstructured":"Che Y, Assanangkornchai S, McNeil E, Chongsuvivatwong V, Li J, Geater A, You J: Predictors of early dropout in methadone maintenance treatment program in Yunnan province, China. Drug Alcohol Rev. 2010, 29 (3): 263-270. 10.1111\/j.1465-3362.2009.00157.x.","journal-title":"Drug Alcohol Rev"},{"issue":"5","key":"1145_CR30","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.addbeh.2004.09.004","volume":"30","author":"CJ Strike","year":"2005","unstructured":"Strike CJ, Gnam W, Urbanoski K, Fischer B, Marsh DC, Millson M: Factors predicting 2-year retention in methadone maintenance treatment for opioid dependence. Addict Behav. 2005, 30 (5): 1025-1028. 10.1016\/j.addbeh.2004.09.004.","journal-title":"Addict Behav"},{"issue":"2","key":"1145_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0376-8716(95)01205-2","volume":"40","author":"A Goldstein","year":"1995","unstructured":"Goldstein A, Herrera J: Heroin addicts and methadone treatment in Albuquerque: a 22-year follow-up. Drug Alcohol Depend. 1995, 40 (2): 139-150. 10.1016\/0376-8716(95)01205-2.","journal-title":"Drug Alcohol Depend"},{"key":"1145_CR32","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1192\/bjp.154.3.348","volume":"154","author":"M Gossop","year":"1989","unstructured":"Gossop M, Green L, Phillips G, Bradley B: Lapse, relapse and survival among opiate addicts after treatment. A prospective follow-up study. Br J Psychiatry. 1989, 154: 348-353. 10.1192\/bjp.154.3.348.","journal-title":"Br J Psychiatry"},{"key":"1145_CR33","volume-title":"The effectiveness of methadone maintenance treatment: patients, programs, services and outcome","year":"1991","unstructured":"The effectiveness of methadone maintenance treatment: patients, programs, services and outcome. Edited by: Ball JC, Ross A. 1991, New York; Berlin etc: Springer-Verl"},{"issue":"1","key":"1145_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.drugalcdep.2005.05.010","volume":"81","author":"J Bell","year":"2006","unstructured":"Bell J, Burrell T, Indig D, Gilmour S: Cycling in and out of treatment; participation in methadone treatment in NSW, 1990\u20132002. Drug Alcohol Depend. 2006, 81 (1): 55-61. 10.1016\/j.drugalcdep.2005.05.010.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"1145_CR35","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1360-0443.2006.01714.x","volume":"102","author":"A Fugelstad","year":"2007","unstructured":"Fugelstad A, Stenbacka M, Leifman A, Nylander M, Thiblin I: Methadone maintenance treatment: the balance between life-saving treatment and fatal poisonings. Addiction. 2007, 102 (3): 406-412. 10.1111\/j.1360-0443.2006.01714.x.","journal-title":"Addiction"},{"issue":"8","key":"1145_CR36","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/j.1360-0443.2009.02570.x","volume":"104","author":"T Clausen","year":"2009","unstructured":"Clausen T, Waal H, Thoresen M, Gossop M: Mortality among opiate users: opioid maintenance therapy, age and causes of death. Addiction. 2009, 104 (8): 1356-1362. 10.1111\/j.1360-0443.2009.02570.x.","journal-title":"Addiction"},{"key":"1145_CR37","volume-title":"Analyse de la statistique des traitements \u00e0 la m\u00e9thadone dans le canton de Vaud: P\u00e9riode 2001\u20132008","author":"T Huissoud","year":"2010","unstructured":"Huissoud T, Gumy C, Gervasoni J-P, Dubois-Arber F: Analyse de la statistique des traitements \u00e0 la m\u00e9thadone dans le canton de Vaud: P\u00e9riode 2001\u20132008. 2010, Lausanne: Institut universitaire de m\u00e9decine sociale et pr\u00e9ventive"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-12-238.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-12-238\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-12-238","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-12-238.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:11:09Z","timestamp":1630530669000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-12-238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1145"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-12-238","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"24 May 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"238"}}